Outcome of adult respiratory failure patients receiving prolonged (≥ 14 Days) ECMO

Annals of Surgery

Volumn 263, Issue 3, 2016, Pages 573-581

  Posluszny, Joseph ^a   Rycus, Peter T ^b   Bartlett, Robert H ^a   Engoren, Milo ^a   Haft, Jonathan W ^a   Lynch, William R ^c   Park, Pauline K ^a   Raghavendran, Krishnan ^a   Napolitano, Lena M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Extracorporeal Life Support Organization   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acute respiratory distress syndrome; acute respiratory failure; extracorporeal membrane oxygenation; outcome; prolonged duration

Indexed keywords

ACUTE RESPIRATORY FAILURE; ADULT; AGE; AGED; ASPERGILLOSIS; ASTHMA; BACTERIAL PNEUMONIA; BILIARY TRACT CANCER; BLEEDING; BLOOD OXYGEN TENSION; CANNULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EMPHYSEMA; ESCHERICHIA COLI INFECTION; ESOPHAGUS CANCER; EXTRACORPOREAL OXYGENATION; FAMILY; FAMILY REQUEST; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HOSPITAL DISCHARGE; HUMAN; ICD-9; LEGIONNAIRE DISEASE; LEUKEMIA; LUNG CANCER; LUNG EMBOLISM; LUNG FIBROSIS; LUNG TRANSPLANTATION; LUNG TUBERCULOSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROLONGED EXTRACORPOREAL MEMBRANE OXYGENATION; PULMONARY ASPIRATION; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SEPSIS; STAPHYLOCOCCUS INFECTION; STOMACH CANCER; STREPTOCOCCUS PNEUMONIA; SURGICAL MORTALITY; SURVIVAL; SURVIVOR; TESTIS CANCER; TREATMENT DURATION; TREATMENT WITHDRAWAL; VENOARTERIAL CANNULATION; VENOVENOUS CANNULATION; VIRUS PNEUMONIA; ADOLESCENT; MIDDLE AGED; REGISTER; RESPIRATORY INSUFFICIENCY; RISK FACTOR; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RESPIRATORY INSUFFICIENCY; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84959372413     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001176     Document Type: Conference Paper

References (31)

1. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-2533.
2. Guerin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159-2168.
3. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107-1116.
4. Towfigh S, Peralta MV, Martin MJ, et al. Acute respiratory distress syndrome in nontrauma surgical patients: a 6-year study. J Trauma. 2009;67:1239-1243.
5. Stewart RM, Park PK, Hunt JP, et al. National Institutes of Health/National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Less is more: improved outcomes in surgical patients with conservative fluid administration and central venous catheter monitoring. J Am Coll Surg. 2009;208:725-735; discussion 735-737.
6. Brogan TV, Thiagarajan RR, Rycus PT, et al. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multicenter database. Intensive Care Med. 2009;35:2105-2114.
7. Schmidt M, Bailey M, Sheldrake J, et al. Predicting survival after ECMO for severe acute respiratory failure: the Respiratory ECMO Survival Prediction (RESP)-Score. Am J Respir Crit Care Med. 2014;189:1374-1382.
8. Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302:1888-1895.
9. Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA. 2011;306:1659-1668.
10. Paden ML, Conrad SA, Rycus PT, et al. Extracorporeal life support organization registry report 2012. ASAIO J. 2013;59:202-210.
11. Chimot L, Marqué S, Gros A, et al. Avalon( bicaval dual-lumen cannula for venovenous extracorporeal membrane oxygenation: survey of cannula use in France. ASAIO J. 2013;59:157-161.
12. Peek GJ,Mugford M, Tiruvoipati R, et al. CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351-1363.
13. Napolitano LM, Angus DC, Uyeki TM. Critically ill patients with influenza A(H1N1)pdm09 virus infection in 2014. JAMA. 2014;311:1289-1290.
14. Pham T, Combes A, Rozé H, et al. REVA Research Network. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2013;187:276-285.
15. Freed DH, Henzler D, White CW, et al., Canadian Critical Care Trials Group. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth. 2010;57:240-247.
16. Roch A, Lepaul-Ercole R, Grisoli D, et al. Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study. Intensive Care Med. 2010; 36:1899-1905.
17. Sadahiro T, Oda S, Nakamura M, et al. Trends in and perspectives on extracorporeal membrane oxygenation for severe adult respiratory failure. Gen Thorac Cardiovasc Surg. 2012;60:192-201.
18. Rosenberg AA, Haft JW, Bartlett R, et al. Prolonged duration ECMO for ARDS: futility, native lung recovery, or transplantation? ASAIO J. 2013;59:642-650.
19. Camboni D, Philipp A, Lubnow M, et al. Support time-dependent outcome analysis for veno-venous extracorporeal membrane oxygenation. Eur J Cardiothorac Surg. 2011;40:1341-1346; discussion 1346-1347.
20. Brogan TV, Zabrocki L, Thiagarajan RR, et al. Prolonged extracorporeal membrane oxygenation for children with respiratory failure. Pediatric Crit Care Med. 2012;13:249-254.
21. Hemmila MR, Rowe SA, Boules TN, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg. 2004;240:595-605; discussion 605-607.
22. Lindskov C, Jensen RH, Sprogoe P, et al. Extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure. Acta Anaesthesiol Scand. 2013;57:303-311.
23. Available at: https://www.elso.org/Registry/Statistics.aspx. Accessed August 17, 2014.
24. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857-872.
25. MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: Life support in the new era. Intensive Care Med. 2012;38:210-220.
26. Pranikoff T, Hirschl RB, Steimle CN, et al. Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Crit Care Med. 1997;25:28-32.
27. ClinicalTrials.gov. Extracorporeal Membrane oxygenation for severe acute respiratory distress syndrome (EOLIA). Available at: http://clinicaltrials.gov/show/NCT01470703. Accessed August 17, 2014.
28. Teman NR, Haft JW, Napolitano LM. Optimal endovascular methods for placement of bicaval dual-lumen cannulae for venovenous extracorporeal membrane oxygenation. ASAIO J. 2013;59:442-447.
29. Lang G, Taghavi S, Aigner C, et al. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation. 2012;93:729-736.
30. Maggio P, Hemmila M, Haft J, et al. Extracorporeal life support for massive pulmonary embolism. J Trauma. 2007;62:570-576.
31. Calfee CS, Delucchi K, Parsons PE, et al. The NHLBI ARDS Network. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2: 611-620.